20/20 Biolabs, Inc. Liquidation Value
AIDX
Other
Cash & Equivalents
$1.03M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $1.03M
Total Obligations: -$3.13M
$-2.10M
Per share: $-0.39
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $1.03M
AR: $199,954
Total Obligations: -$3.13M
$-1.90M
Per share: $-0.35
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $1.03M
AR: $199,954
Inventory: $116,217
Total Obligations: -$3.13M
$-1.79M
Per share: $-0.33
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $-2.10M | $-0.39 |
| Liquid Liquidation Value | $-1.90M | $-0.35 |
| Operating Liquidation Value | $-1.79M | $-0.33 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $1.03M |
| Accounts Receivable | $199,954 |
| Inventory | $116,217 |
| Current Liabilities | $2.46M |
| Long-term Debt | N/A |
| Op. Lease Liability | $664,673 |
| Finance Lease | N/A |
| Shares Outstanding | 5.4M |
Explore all 462 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $1.03M | $199,954 | $116,217 | $868,545 | $2.46M | N/A | $664,673 | N/A |
| 2024-12-31 | $1.78M | $135,272 | $47,164 | $372,303 | $1.36M | N/A | $839,550 | N/A |
SEC Filings
| Period | Form | Filed | Link |
|---|---|---|---|
| 2025-12-31 | 10-K | 2026-03-31 | View |
▼ Community Notes